| ICD-10 Code | Description |
| T44.0X1A | Poisoning by anticholinesterase agents, accidental (unintentional), initial encounter |
| T44.0X1D | Poisoning by anticholinesterase agents, accidental (unintentional), subsequent encounter |
| T44.0X1S | Poisoning by anticholinesterase agents, accidental (unintentional), sequela |
| T44.0X2A | Poisoning by anticholinesterase agents, intentional self-harm, initial encounter |
| T44.0X2D | Poisoning by anticholinesterase agents, intentional self-harm, subsequent encounter |
| T44.0X2S | Poisoning by anticholinesterase agents, intentional self-harm, sequela |
| T44.0X3A | Poisoning by anticholinesterase agents, assault, initial encounter |
| T44.0X3D | Poisoning by anticholinesterase agents, assault, subsequent encounter |
| T44.0X3S | Poisoning by anticholinesterase agents, assault, sequela |
| T44.0X4A | Poisoning by anticholinesterase agents, undetermined, initial encounter |
| T44.0X4D | Poisoning by anticholinesterase agents, undetermined, subsequent encounter |
| T44.0X4S | Poisoning by anticholinesterase agents, undetermined, sequela |
| T44.0X5A | Adverse effect of anticholinesterase agents, initial encounter |
| T44.0X5D | Adverse effect of anticholinesterase agents, subsequent encounter |
| T44.0X5S | Adverse effect of anticholinesterase agents, sequela |
| T44.0X6A | Underdosing of anticholinesterase agents, initial encounter |
| T44.0X6D | Underdosing of anticholinesterase agents, subsequent encounter |
| T44.0X6S | Underdosing of anticholinesterase agents, sequela |
| T44.1X1A | Poisoning by other parasympathomimetics [cholinergics], accidental (unintentional), initial encounter |
| T44.1X1D | Poisoning by other parasympathomimetics [cholinergics], accidental (unintentional), subsequent encounter |
| T44.1X1S | Poisoning by other parasympathomimetics [cholinergics], accidental (unintentional), sequela |
| T44.1X2A | Poisoning by other parasympathomimetics [cholinergics], intentional self-harm, initial encounter |
| T44.1X2D | Poisoning by other parasympathomimetics [cholinergics], intentional self-harm, subsequent encounter |
| T44.1X2S | Poisoning by other parasympathomimetics [cholinergics], intentional self-harm, sequela |
| T44.1X3A | Poisoning by other parasympathomimetics [cholinergics], assault, initial encounter |
| T44.1X3D | Poisoning by other parasympathomimetics [cholinergics], assault, subsequent encounter |
| T44.1X3S | Poisoning by other parasympathomimetics [cholinergics], assault, sequela |
| T44.1X4A | Poisoning by other parasympathomimetics [cholinergics], undetermined, initial encounter |
| T44.1X4D | Poisoning by other parasympathomimetics [cholinergics], undetermined, subsequent encounter |
| T44.1X4S | Poisoning by other parasympathomimetics [cholinergics], undetermined, sequela |
| T44.1X5A | Adverse effect of other parasympathomimetics [cholinergics], initial encounter |
| T44.1X5D | Adverse effect of other parasympathomimetics [cholinergics], subsequent encounter |
| T44.1X5S | Adverse effect of other parasympathomimetics [cholinergics], sequela |
| T44.1X6A | Underdosing of other parasympathomimetics [cholinergics], initial encounter |
| T44.1X6D | Underdosing of other parasympathomimetics [cholinergics], subsequent encounter |
| T44.1X6S | Underdosing of other parasympathomimetics [cholinergics], sequela |
| T44.2X1A | Poisoning by ganglionic blocking drugs, accidental (unintentional), initial encounter |
| T44.2X1D | Poisoning by ganglionic blocking drugs, accidental (unintentional), subsequent encounter |
| T44.2X1S | Poisoning by ganglionic blocking drugs, accidental (unintentional), sequela |
| T44.2X2A | Poisoning by ganglionic blocking drugs, intentional self-harm, initial encounter |
| T44.2X2D | Poisoning by ganglionic blocking drugs, intentional self-harm, subsequent encounter |
| T44.2X2S | Poisoning by ganglionic blocking drugs, intentional self-harm, sequela |
| T44.2X3A | Poisoning by ganglionic blocking drugs, assault, initial encounter |
| T44.2X3D | Poisoning by ganglionic blocking drugs, assault, subsequent encounter |
| T44.2X3S | Poisoning by ganglionic blocking drugs, assault, sequela |
| T44.2X4A | Poisoning by ganglionic blocking drugs, undetermined, initial encounter |
| T44.2X4D | Poisoning by ganglionic blocking drugs, undetermined, subsequent encounter |
| T44.2X4S | Poisoning by ganglionic blocking drugs, undetermined, sequela |
| T44.2X5A | Adverse effect of ganglionic blocking drugs, initial encounter |
| T44.2X5D | Adverse effect of ganglionic blocking drugs, subsequent encounter |
| T44.2X5S | Adverse effect of ganglionic blocking drugs, sequela |
| T44.2X6A | Underdosing of ganglionic blocking drugs, initial encounter |
| T44.2X6D | Underdosing of ganglionic blocking drugs, subsequent encounter |
| T44.2X6S | Underdosing of ganglionic blocking drugs, sequela |
| T44.3X1A | Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, accidental (unintentional), initial encounter |
| T44.3X1D | Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, accidental (unintentional), subsequent encounter |
| T44.3X1S | Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, accidental (unintentional), sequela |
| T44.3X2A | Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, intentional self-harm, initial encounter |
| T44.3X2D | Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, intentional self-harm, subsequent encounter |
| T44.3X2S | Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, intentional self-harm, sequela |
| T44.3X3A | Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, assault, initial encounter |
| T44.3X3D | Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, assault, subsequent encounter |
| T44.3X3S | Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, assault, sequela |
| T44.3X4A | Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, undetermined, initial encounter |
| T44.3X4D | Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, undetermined, subsequent encounter |
| T44.3X4S | Poisoning by other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, undetermined, sequela |
| T44.3X5A | Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter |
| T44.3X5D | Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, subsequent encounter |
| T44.3X5S | Adverse effect of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, sequela |
| T44.3X6A | Underdosing of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, initial encounter |
| T44.3X6D | Underdosing of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, subsequent encounter |
| T44.3X6S | Underdosing of other parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics, sequela |
| T44.4X1A | Poisoning by predominantly alpha-adrenoreceptor agonists, accidental (unintentional), initial encounter |
| T44.4X1D | Poisoning by predominantly alpha-adrenoreceptor agonists, accidental (unintentional), subsequent encounter |
| T44.4X1S | Poisoning by predominantly alpha-adrenoreceptor agonists, accidental (unintentional), sequela |
| T44.4X2A | Poisoning by predominantly alpha-adrenoreceptor agonists, intentional self-harm, initial encounter |
| T44.4X2D | Poisoning by predominantly alpha-adrenoreceptor agonists, intentional self-harm, subsequent encounter |
| T44.4X2S | Poisoning by predominantly alpha-adrenoreceptor agonists, intentional self-harm, sequela |
| T44.4X3A | Poisoning by predominantly alpha-adrenoreceptor agonists, assault, initial encounter |
| T44.4X3D | Poisoning by predominantly alpha-adrenoreceptor agonists, assault, subsequent encounter |
| T44.4X3S | Poisoning by predominantly alpha-adrenoreceptor agonists, assault, sequela |
| T44.4X4A | Poisoning by predominantly alpha-adrenoreceptor agonists, undetermined, initial encounter |
| T44.4X4D | Poisoning by predominantly alpha-adrenoreceptor agonists, undetermined, subsequent encounter |
| T44.4X4S | Poisoning by predominantly alpha-adrenoreceptor agonists, undetermined, sequela |
| T44.4X5A | Adverse effect of predominantly alpha-adrenoreceptor agonists, initial encounter |
| T44.4X5D | Adverse effect of predominantly alpha-adrenoreceptor agonists, subsequent encounter |
| T44.4X5S | Adverse effect of predominantly alpha-adrenoreceptor agonists, sequela |
| T44.4X6A | Underdosing of predominantly alpha-adrenoreceptor agonists, initial encounter |
| T44.4X6D | Underdosing of predominantly alpha-adrenoreceptor agonists, subsequent encounter |
| T44.4X6S | Underdosing of predominantly alpha-adrenoreceptor agonists, sequela |
| T44.5X1A | Poisoning by predominantly beta-adrenoreceptor agonists, accidental (unintentional), initial encounter |
| T44.5X1D | Poisoning by predominantly beta-adrenoreceptor agonists, accidental (unintentional), subsequent encounter |
| T44.5X1S | Poisoning by predominantly beta-adrenoreceptor agonists, accidental (unintentional), sequela |
| T44.5X2A | Poisoning by predominantly beta-adrenoreceptor agonists, intentional self-harm, initial encounter |
| T44.5X2D | Poisoning by predominantly beta-adrenoreceptor agonists, intentional self-harm, subsequent encounter |
| T44.5X2S | Poisoning by predominantly beta-adrenoreceptor agonists, intentional self-harm, sequela |
| T44.5X3A | Poisoning by predominantly beta-adrenoreceptor agonists, assault, initial encounter |
| T44.5X3D | Poisoning by predominantly beta-adrenoreceptor agonists, assault, subsequent encounter |
| T44.5X3S | Poisoning by predominantly beta-adrenoreceptor agonists, assault, sequela |
| T44.5X4A | Poisoning by predominantly beta-adrenoreceptor agonists, undetermined, initial encounter |
| T44.5X4D | Poisoning by predominantly beta-adrenoreceptor agonists, undetermined, subsequent encounter |
| T44.5X4S | Poisoning by predominantly beta-adrenoreceptor agonists, undetermined, sequela |
| T44.5X5A | Adverse effect of predominantly beta-adrenoreceptor agonists, initial encounter |
| T44.5X5D | Adverse effect of predominantly beta-adrenoreceptor agonists, subsequent encounter |
| T44.5X5S | Adverse effect of predominantly beta-adrenoreceptor agonists, sequela |
| T44.5X6A | Underdosing of predominantly beta-adrenoreceptor agonists, initial encounter |
| T44.5X6D | Underdosing of predominantly beta-adrenoreceptor agonists, subsequent encounter |
| T44.5X6S | Underdosing of predominantly beta-adrenoreceptor agonists, sequela |
| T44.6X1A | Poisoning by alpha-adrenoreceptor antagonists, accidental (unintentional), initial encounter |
| T44.6X1D | Poisoning by alpha-adrenoreceptor antagonists, accidental (unintentional), subsequent encounter |
| T44.6X1S | Poisoning by alpha-adrenoreceptor antagonists, accidental (unintentional), sequela |
| T44.6X2A | Poisoning by alpha-adrenoreceptor antagonists, intentional self-harm, initial encounter |
| T44.6X2D | Poisoning by alpha-adrenoreceptor antagonists, intentional self-harm, subsequent encounter |
| T44.6X2S | Poisoning by alpha-adrenoreceptor antagonists, intentional self-harm, sequela |
| T44.6X3A | Poisoning by alpha-adrenoreceptor antagonists, assault, initial encounter |
| T44.6X3D | Poisoning by alpha-adrenoreceptor antagonists, assault, subsequent encounter |
| T44.6X3S | Poisoning by alpha-adrenoreceptor antagonists, assault, sequela |
| T44.6X4A | Poisoning by alpha-adrenoreceptor antagonists, undetermined, initial encounter |
| T44.6X4D | Poisoning by alpha-adrenoreceptor antagonists, undetermined, subsequent encounter |
| T44.6X4S | Poisoning by alpha-adrenoreceptor antagonists, undetermined, sequela |
| T44.6X5A | Adverse effect of alpha-adrenoreceptor antagonists, initial encounter |
| T44.6X5D | Adverse effect of alpha-adrenoreceptor antagonists, subsequent encounter |
| T44.6X5S | Adverse effect of alpha-adrenoreceptor antagonists, sequela |
| T44.6X6A | Underdosing of alpha-adrenoreceptor antagonists, initial encounter |
| T44.6X6D | Underdosing of alpha-adrenoreceptor antagonists, subsequent encounter |
| T44.6X6S | Underdosing of alpha-adrenoreceptor antagonists, sequela |
| T44.7X1A | Poisoning by beta-adrenoreceptor antagonists, accidental (unintentional), initial encounter |
| T44.7X1D | Poisoning by beta-adrenoreceptor antagonists, accidental (unintentional), subsequent encounter |
| T44.7X1S | Poisoning by beta-adrenoreceptor antagonists, accidental (unintentional), sequela |
| T44.7X2A | Poisoning by beta-adrenoreceptor antagonists, intentional self-harm, initial encounter |
| T44.7X2D | Poisoning by beta-adrenoreceptor antagonists, intentional self-harm, subsequent encounter |
| T44.7X2S | Poisoning by beta-adrenoreceptor antagonists, intentional self-harm, sequela |
| T44.7X3A | Poisoning by beta-adrenoreceptor antagonists, assault, initial encounter |
| T44.7X3D | Poisoning by beta-adrenoreceptor antagonists, assault, subsequent encounter |
| T44.7X3S | Poisoning by beta-adrenoreceptor antagonists, assault, sequela |
| T44.7X4A | Poisoning by beta-adrenoreceptor antagonists, undetermined, initial encounter |
| T44.7X4D | Poisoning by beta-adrenoreceptor antagonists, undetermined, subsequent encounter |
| T44.7X4S | Poisoning by beta-adrenoreceptor antagonists, undetermined, sequela |
| T44.7X5A | Adverse effect of beta-adrenoreceptor antagonists, initial encounter |
| T44.7X5D | Adverse effect of beta-adrenoreceptor antagonists, subsequent encounter |
| T44.7X5S | Adverse effect of beta-adrenoreceptor antagonists, sequela |
| T44.7X6A | Underdosing of beta-adrenoreceptor antagonists, initial encounter |
| T44.7X6D | Underdosing of beta-adrenoreceptor antagonists, subsequent encounter |
| T44.7X6S | Underdosing of beta-adrenoreceptor antagonists, sequela |
| T44.8X1A | Poisoning by centrally-acting and adrenergic-neuron-blocking agents, accidental (unintentional), initial encounter |
| T44.8X1D | Poisoning by centrally-acting and adrenergic-neuron-blocking agents, accidental (unintentional), subsequent encounter |
| T44.8X1S | Poisoning by centrally-acting and adrenergic-neuron-blocking agents, accidental (unintentional), sequela |
| T44.8X2A | Poisoning by centrally-acting and adrenergic-neuron-blocking agents, intentional self-harm, initial encounter |
| T44.8X2D | Poisoning by centrally-acting and adrenergic-neuron-blocking agents, intentional self-harm, subsequent encounter |
| T44.8X2S | Poisoning by centrally-acting and adrenergic-neuron-blocking agents, intentional self-harm, sequela |
| T44.8X3A | Poisoning by centrally-acting and adrenergic-neuron-blocking agents, assault, initial encounter |
| T44.8X3D | Poisoning by centrally-acting and adrenergic-neuron-blocking agents, assault, subsequent encounter |
| T44.8X3S | Poisoning by centrally-acting and adrenergic-neuron-blocking agents, assault, sequela |
| T44.8X4A | Poisoning by centrally-acting and adrenergic-neuron-blocking agents, undetermined, initial encounter |
| T44.8X4D | Poisoning by centrally-acting and adrenergic-neuron-blocking agents, undetermined, subsequent encounter |
| T44.8X4S | Poisoning by centrally-acting and adrenergic-neuron-blocking agents, undetermined, sequela |
| T44.8X5A | Adverse effect of centrally-acting and adrenergic-neuron-blocking agents, initial encounter |
| T44.8X5D | Adverse effect of centrally-acting and adrenergic-neuron-blocking agents, subsequent encounter |
| T44.8X5S | Adverse effect of centrally-acting and adrenergic-neuron-blocking agents, sequela |
| T44.8X6A | Underdosing of centrally-acting and adrenergic-neuron-blocking agents, initial encounter |
| T44.8X6D | Underdosing of centrally-acting and adrenergic-neuron-blocking agents, subsequent encounter |
| T44.8X6S | Underdosing of centrally-acting and adrenergic-neuron-blocking agents, sequela |
| T44.901A | Poisoning by unspecified drugs primarily affecting the autonomic nervous system, accidental (unintentional), initial encounter |
| T44.901D | Poisoning by unspecified drugs primarily affecting the autonomic nervous system, accidental (unintentional), subsequent encounter |
| T44.901S | Poisoning by unspecified drugs primarily affecting the autonomic nervous system, accidental (unintentional), sequela |
| T44.902A | Poisoning by unspecified drugs primarily affecting the autonomic nervous system, intentional self-harm, initial encounter |
| T44.902D | Poisoning by unspecified drugs primarily affecting the autonomic nervous system, intentional self-harm, subsequent encounter |
| T44.902S | Poisoning by unspecified drugs primarily affecting the autonomic nervous system, intentional self-harm, sequela |
| T44.903A | Poisoning by unspecified drugs primarily affecting the autonomic nervous system, assault, initial encounter |
| T44.903D | Poisoning by unspecified drugs primarily affecting the autonomic nervous system, assault, subsequent encounter |
| T44.903S | Poisoning by unspecified drugs primarily affecting the autonomic nervous system, assault, sequela |
| T44.904A | Poisoning by unspecified drugs primarily affecting the autonomic nervous system, undetermined, initial encounter |
| T44.904D | Poisoning by unspecified drugs primarily affecting the autonomic nervous system, undetermined, subsequent encounter |
| T44.904S | Poisoning by unspecified drugs primarily affecting the autonomic nervous system, undetermined, sequela |
| T44.905A | Adverse effect of unspecified drugs primarily affecting the autonomic nervous system, initial encounter |
| T44.905D | Adverse effect of unspecified drugs primarily affecting the autonomic nervous system, subsequent encounter |
| T44.905S | Adverse effect of unspecified drugs primarily affecting the autonomic nervous system, sequela |
| T44.906A | Underdosing of unspecified drugs primarily affecting the autonomic nervous system, initial encounter |
| T44.906D | Underdosing of unspecified drugs primarily affecting the autonomic nervous system, subsequent encounter |
| T44.906S | Underdosing of unspecified drugs primarily affecting the autonomic nervous system, sequela |
| T44.991A | Poisoning by other drug primarily affecting the autonomic nervous system, accidental (unintentional), initial encounter |
| T44.991D | Poisoning by other drug primarily affecting the autonomic nervous system, accidental (unintentional), subsequent encounter |
| T44.991S | Poisoning by other drug primarily affecting the autonomic nervous system, accidental (unintentional), sequela |
| T44.992A | Poisoning by other drug primarily affecting the autonomic nervous system, intentional self-harm, initial encounter |
| T44.992D | Poisoning by other drug primarily affecting the autonomic nervous system, intentional self-harm, subsequent encounter |
| T44.992S | Poisoning by other drug primarily affecting the autonomic nervous system, intentional self-harm, sequela |
| T44.993A | Poisoning by other drug primarily affecting the autonomic nervous system, assault, initial encounter |
| T44.993D | Poisoning by other drug primarily affecting the autonomic nervous system, assault, subsequent encounter |
| T44.993S | Poisoning by other drug primarily affecting the autonomic nervous system, assault, sequela |
| T44.994A | Poisoning by other drug primarily affecting the autonomic nervous system, undetermined, initial encounter |
| T44.994D | Poisoning by other drug primarily affecting the autonomic nervous system, undetermined, subsequent encounter |
| T44.994S | Poisoning by other drug primarily affecting the autonomic nervous system, undetermined, sequela |
| T44.995A | Adverse effect of other drug primarily affecting the autonomic nervous system, initial encounter |
| T44.995D | Adverse effect of other drug primarily affecting the autonomic nervous system, subsequent encounter |
| T44.995S | Adverse effect of other drug primarily affecting the autonomic nervous system, sequela |
| T44.996A | Underdosing of other drug primarily affecting the autonomic nervous system, initial encounter |
| T44.996D | Underdosing of other drug primarily affecting the autonomic nervous system, subsequent encounter |
| T44.996S | Underdosing of other drug primarily affecting the autonomic nervous system, sequela |
